Can improved research designs answer questions that arise between physicians and patients, such as a better understanding of the risks and benefits of prescription drugs for Attention Deficit Hyperactivity Disorder (ADHD)? Brian M. D’Onofrio, PhD, presented translational epidemiology in a talk titled The Risks and Benefits of ADHD: A PharmacoepidemiologicRead More →